Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Avinger IncAVGR · Entity 83897 | Director | June 14, 2017 | June 15, 2017 |
| PULSE BIOSCIENCES, INC.PLSE · Entity 1151 | Director | May 16, 2019 | May 17, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Avinger Inc
Report date June 14, 2017 · Filed June 15, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.38 · Expires 2027-06-14 | Direct | 199,304 |
Reported balance
After 2017-06-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-06-14 · Grant · Acquired 92,609 · Balance 199,304 F1: The stock options vest 100% on the anniversary of the transaction date. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options vest 100% on the anniversary of the transaction date.
PULSE BIOSCIENCES, INC.
Report date May 16, 2019 · Filed May 17, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.03 · Expires 2029-05-16 | Direct | 15,000 |
Reported balance
After 2019-05-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-05-16 · Grant · Acquired 15,000 · Balance 15,000 F1: The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.03 · Expires 2029-05-16 | Direct | 10,706 |
Reported balance
After 2019-05-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-05-16 · Grant · Acquired 10,706 · Balance 10,706 F2: The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date.
F2: The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 16, 2019 Filed May 17, 2019 16:16 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 10,706 | $0.00 Strike: $13.03 | $0.00 |
DisclosureSEC source: 0001209191-19-030893 · doc4.xml · derivative · entry 2 FOGARTY THOMAS J M D · CIK 0001032298 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,706 Underlying: Common Stock · 10,706 shares Expires 2029-05-16 F2 · derivative.exercise_date: The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| May 16, 2019 Filed May 17, 2019 16:16 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $13.03 | $0.00 |
DisclosureSEC source: 0001209191-19-030893 · doc4.xml · derivative · entry 1 FOGARTY THOMAS J M D · CIK 0001032298 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2029-05-16 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| January 07, 2019 Filed Jan 9, 2019 16:14 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 3,498 | $0.00 Strike: $13.22 | $0.00 |
DisclosureSEC source: 0001209191-19-003036 · doc4.xml · derivative · entry 1 FOGARTY THOMAS J M D · CIK 0001032298 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,498 Underlying: Common Stock · 3,498 shares Expires 2029-01-07 F1 · derivative.exercise_date: The shares subject to the option will fully vest on the date of the Issuer's Annual Meeting to be held in 2019, subject to the Reporting Person's continued service through such vesting date. Read SEC document |
| May 23, 2018 Filed May 24, 2018 18:36 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $15.27 | $0.00 |
DisclosureSEC source: 0001209191-18-033152 · doc4.xml · derivative · entry 1 FOGARTY THOMAS J M D · CIK 0001032298 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2028-05-23 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 16:43 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $23.08 | $0.00 |
DisclosureSEC source: 0001209191-17-059427 · doc4.xml · derivative · entry 1 FOGARTY THOMAS J M D · CIK 0001032298 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2027-11-02 F1 · derivative.exercise_date: One-third (1/3) of the shares subject to the option will vest on November 2, 2018, and the remaining shares will vest in equal monthly installments thereafter over the following two year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 17:12 UTC | Avinger Inc AVGR · Entity 83897 | GrantOption (right to buy) · Derivative | 92,609 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001593968-17-000795 · primary_01.xml · derivative · entry 1 FOGARTY THOMAS J M D · CIK 0001032298 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,304 Underlying: Common Stock · 92,609 shares Expires 2027-06-14 F1 · derivative.exercise_date: The stock options vest 100% on the anniversary of the transaction date. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 18:35 UTC | Avinger Inc AVGR · Entity 83897 | GrantOption (right to buy) · Derivative | 69,473 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001593968-17-000446 · primary_01.xml · derivative · entry 1 FOGARTY THOMAS J M D · CIK 0001032298 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,695 Underlying: Common Stock · 69,473 shares Expires 2027-03-13 F1 · derivative.exercise_date: The stock options vest 100% on the anniversary of the transaction date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.